Fig. 4From: Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemiaGraphs showing Kaplan-Meier analysis of overall and event free survival by transcript type. Event free survival defined as survival in the absence of death, blast crisis, failure of therapy requiring change or loss of MMR. Intolerance of therapy was not includedBack to article page